COMMUNICABLE DISEASE CONTROL DEPARTMENT

    Contact provincial rapid response team (RRT)

Title                     

   Home
   Ministry of Health
   Outbreak News
   Communicable Disease
   International Network
   IMCI strategy
   Related News
   Contact CDC Hotline
   Tel : (855) 12 488981
            (855) 12 836868
   Email:cdc_moh@camnet.com.kh
             : touch358@online.com.kh
             : sovann_ly@online.com.kh
 

ASEAN SENIOR OFFICIAL MEETING &
ASEAN HEALTH MINISTER MEETING
ON SARS

Putra Jaya, Malaysia

25-26 April 2003


1- EPIDEMIOLOGY
2- CASE DEFINITION
3- CUMULATIVE NUMBERS
4- AFFECTED AREAS
5- PUBLIC HEALTH MEASURES
6- SITUATION IN CAMBODIA
7- INFORMATION OF CASES AND CONTACTS
8- SHARING OF LABORATORY EXPERTISE
9- SCREENING OF TRAVELERS ON
     PRE DEPARTURE AND ARRIVAL

10- CONTACT PERSONS
11- RECOMMENDATION

 

EPIDEMIOLOGY

nSevere Acute Respiratory Syndrome(SARS) is an atypical pneumonia caused by a new coronavirus

nWHO is coordinating international investigation with the assistance of the Global Alert and Response Network and work closely with health authority of affected countries to provide epidemiological, clinical and logistical support as required

nWHO’s global alert issued on 12 March 2003θheightened surveillance for cases of SARS.

nQuick identification of cases and isolationθlocal transmission is stopped in most countries

nWHO and a network of 13 of the world top laboratories are zeroing in the cause of SARS and a diagnostic test is being developed

nThis will help distinguish those who are infected and those who are free of the disease

n16 April 2003: official announcement of the new pathogen, a member of the coronavirus family never before seen in human as the cause of SARS

nSo far, no certain treatment or vaccine                                                                           

Top of page


CASE DEFINITION
(revised 1 April 2003)

* Suspect case:

1- A person presenting after 1 Nov. 2002 with the history of high fever(>38 degree C), and cough or breathing difficulty and one or more of the following exposures during the 10 days prior to the onset of the symptoms:

      -close contact  with a suspect or probable cases of SARS

      -history of travel to an affected area

      -residing in an affected area

 2- A person with unexplained acute respiratory illness resulting in death after 1 November 2002 but on whom no autopsy  has been performed and one or more of the following exposures during the 10 days prior to the onset of the symptoms:

      -close contact  with a suspect or probable cases of SARS

      -history of travel to an affected area

      -residing in an affected area

* Probable cases:

1- A suspect case with radiologic evidence of infiltrates consistent with pneumonia  or respiratory distress syndrome (RDS) on chest X-ray

2- A suspect case with autopsy findings consistent with the pathology of RDS without an identifiable cause

           

Top of page

CUMULATIVE NUMBERS
AS OF 22 APRIL 2003

nReport from 27 countries and regions

nNumber of reported probable cases: 3,947

nIncrease from previous update: 80

nNumber of deaths: 229

nRecovered: 1595

nThere is so far no reported case in Cambodia                                                                 

Top of page

AFFECTED AREAS
AS OF 22 APRIL 2003

nCanada (Toronto)

nSingapore (Singapore)

nChina (Guangdong province, Hong Kong SAR, Shanxi province, Beijing, Taiwan province, Inner Mongolia)

nUnited States of America*

nUnited Kingdom (London)*

nVietnam (Hanoi)

* Area with limited local transmission and no evidence of international spread since 15 March 2003 and no transmission other than close person-to-person contact reported

Top of page

PUBLIC HEALTH MEASURES

nPublic awareness

nEnhanced surveillance

nProcedure for arrival from affected areas,

ncontact tracing and follow up

ncommunity based isolation of close contact of probable SARS cases

nHospital infection control measures (identification of local facilities for admission, isolation and barrier nursing of possible SARS cases)

nStockpiling of barrier nursing supplies (PPE)                                                                  

Top of page

SITUATION IN CAMBODIA

*Administrative measures:

- A special task force to coordinate the prevention and control of SARS

-5 meetings since mid March 2003

-Inter-ministerial meeting (MFA)

- 4 joint press releases between MOH and WHO

-Directives to airports, seaports and border posts  and the health system including the private sector and military hospitals

- Creation of a hot line

- Update for the public and travel agencies, hotels…

- Supervision at airports

 *Technical measures:

Strong technical support from WHO

Use of WHO guidelines for airports

Use of health declaration cards for travelers

Assign reference centers

Special ambulance for referral of cases

Set up investigation and training teams

Imminent threat even there is so far no reported case in the country

Example of strong collaboration between WHO and IPC and other partners

One month since its designation as reference center, Calmette Hospital treated 12 patients (all discarded)

4,078 travelers filled out Health Declaration Cards (13-23April 2003).                              

Top of page

INFORMATION OF
CASES AND CONTACTS

nUse of Severe Acute Respiratory Syndrome Case Reporting Form of WHO including:

- Reporting details

- Demographic details

- Signs and symptoms

- Chest X-ray

- Hospital admission history

- History of exposure

- Contact tracing

- Initial,current and final case classification

- Final status

                                                             Health Declaration of Travelers
Date (dd/mm/yy):…………………      Port of Entry:…………………………………..
                                             Flight No    and seat No                           Ship                 Car                Bus
Type of transportation:                                                                          
!                    !                  !
Family Name and First name:………………………………………………………………………………..
Sex:…........        Date of Birth (dd/mm/yy):……………………………………………………………….…
Nationality……………………… Passport Number:………………………………………………………..
Country of residence and permanent address:…………………………………………………………….
…………………………………………………………………………………………………………………..
Country(ies) and cities visited during the last 2 weeks (please list all the countries visited with date of arrival and date of departure)
      Country/city                                 Date of  arrival                             Date of departure
-……………………..                        …………………                    ………………………                    
How long will you stay in Cambodia?....................................................................................................
Contact address in Cambodia for the subsequent 14 days (address, tel, contact person):
……………………………………………………………………………………………………………………
Do you have any of the following symptom (tick all that apply)?:
Fever:    
!                       Cough:     !                    Difficulty in breathing:    !                Chills:       !
Other (specify):                                                                                                                    None:      
!
Have you been in contact within 14 days with a person who has been diagnosed with SARS? (tick)
Yes 
!                No    !          don’t know    !
I declare the information given above is true and correct
                                                                                                                     ______________________
                                                                                                                                 Passenger signature
 
                                *Once completed give this part to the health authority/quarantine officer on arrival

Top of page

 

SHARING OF LABORATORY EXPERTISE

nNIPH and Pasteur Institute- Cambodia are designated SARS laboratories for Cambodia

nAvailability of P2+ facility (using P3 practices) and some PCR kits from Hamburg and adapted by Pasteur Institute in Paris

nNetworking with other laboratories

nNeed for more test kits, especially antibody tests for SARS to facilitate case investigations

Top of page

SCREENING OF TRAVELERS ON
PRE DEPARTURE AND ARRIVAL

*Instruction on public health measures to be taken at international airports: (additional measures decided on 4 April 2003)

1- Arriving passengers: fill out SARS Health Alert Card

2- Immediate isolation of suspected cases

3- Transfer to designated facilities by ambulance

4- Follow up of close contact in the next 14 days

5- Airport authority to check whether arriving passengers from affected areas have been screened at departure

6- Provision of a copy of passenger seating list

8- Aircraft that has carried suspected caseθdisinfections according to WHO Guide to Hygiene and Sanitation in Aviation

9- Guidelines for Fire Station Ambulance

10- Personal Protective Equipment (PPE) for Health Officer or Airport staff entering in contact with suspected cases of SARS                                                                                                

Top of page


CONTACT PERSONS

nHE. Prof. Eng Huot, Director General for Health, Tel. 855 16 813 151

nDr. Sok Touch, Director of Communicable Disease Control Department, Tel. 855 12 856 848, Fax: 855 23 882 317, Email: touch358@online.com.kh

nDr. Ly Sovann, Acting Chief of Disease Surveillance Bureau, Tel. 855 12 825 424, Fax: 855 23 882 317 Email: sovann_ly@yahoo.com                                                                                   

 Top of page

RECOMMENDATION

nConsideration of international travel

nHeighten surveillance for pre-departure and transit passengers

nStrengthen regional surveillance (MBDS, ASEAN Disease Surveillance)

nStrengthen border health cooperation

nStrengthen laboratory network

nStockpiling of equipment

nHealth and economic impact of SARS

nEmergency Fund for Outbreak response from Government and Donors                          

Top of page

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Copyright © 2004, CDC department | All right reserved

#151-153, Kampuchea Krom blvd, Phnom Penh, Cambodia